Understanding the patient experience of heart failure with obesity and preserved ejection fraction (HFpEF): qualitative insights from patients and clinicians

Heart failure with preserved ejection fraction (HFpEF) is a heterogenous clinical syndrome. Individuals living with HFpEF and obesity display a distinct phenotype that places considerable burden on their health-related quality of life. This study explored signs, symptoms, and impacts most relevant to individuals living with HFpEF and obesity. Clinician interviews provided a clinical perspective on the patient experience. Qualitative interviews were conducted virtually with adults in the US diagnosed with HFpEF and obesity (body mass index ≥ 30.0 kg/m2). Clinicians in the US, China, and Germany with ≥ 3 years of experience treating HFpEF were also interviewed. Patient interviews were conducted until conceptual saturation was achieved. Content analysis was conducted using Atlas.ti v9.0 software. A conceptual model (CM) of the lived experience of HFpEF and obesity based on patient and clinician feedback was developed. Twenty-two patients and 6 clinicians participated. The CM demonstrated that living with HFpEF impacts many facets of life, with patient and clinician participants reporting impacts on their (or their patients’) physical functioning (e.g., walking), activities of daily living (e.g., household chores) and work. Impacts on emotional well-being (e.g., feeling anxious or worried), social lives, relationships, and sleep were also reported. Shortness of breath and fatigue were spontaneously noted as salient and bothersome symptoms by most patient participants with edema noted by most on probing; this was further corroborated by clinicians who also considered these symptoms as the most bothersome symptoms of HFpEF. This study highlighted the substantial burden of living with HFpEF and obesity. The resultant conceptual model highlights the key concepts that should be considered in patient-focused drug development. This qualitative study involved in-depth interviews with patients and health care professionals to understand the symptoms and impacts of living with heart failure with preserved ejection fraction (HFpEF) and obesity. Findings identified fatigue, shortness of breath, and swelling caused by excess fluid (edema) as core symptoms experienced by patients which subsequently impacted multiple aspects of patients’ lives including physical functioning (e.g., walking), ability to do everyday tasks (e.g., household chores), work, emotions, and sleep. The conceptual model summarizing the identified symptoms and impacts is the first to illustrate the experience of living with HFpEF and obesity and can inform future research and clinical trials for this condition.

Authors

Institutions

Publication Details

Journal
Journal of Patient-Reported Outcomes
Published
2026-01-21
DOI
https://doi.org/10.1186/s41687-026-00998-2
Citations
1
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
30.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding the patient experience of heart failure with obesity and preserved ejection fraction (HFpEF): qualitative insights from patients and clinicians

CHLOE CARMICHAEL, JIAT LING POON, SHRADDHA SHINDE, Gemma Al-Jassar et al.
1 citations
Journal of Patient-Reported Outcomes
Cardiovascular Function and Risk Factors
30.07
article

Understanding the patient experience of heart failure with obesity and preserved ejection fraction (HFpEF): qualitative insights from patients and clinicians

CHLOE CARMICHAEL, JIAT LING POON, SHRADDHA SHINDE, Gemma Al-Jassar, CHRIS MARSHALL, Chisom Kanu, Jordan Miller
article en
1 citations

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a heterogenous clinical syndrome. Individuals living with HFpEF and obesity display a distinct phenotype that places considerable burden on their health-related quality of life. This study explored signs, symptoms, and impacts most relevant to individuals living with HFpEF and obesity. Clinician interviews provided a clinical perspective on the patient experience. Qualitative interviews were conducted virtually with adults in the US diagnosed with HFpEF and obesity (body mass index ≥ 30.0 kg/m2). Clinicians in the US, China, and Germany with ≥ 3 years of experience treating HFpEF were also interviewed. Patient interviews were conducted until conceptual saturation was achieved. Content analysis was conducted using Atlas.ti v9.0 software. A conceptual model (CM) of the lived experience of HFpEF and obesity based on patient and clinician feedback was developed. Twenty-two patients and 6 clinicians participated. The CM demonstrated that living with HFpEF impacts many facets of life, with patient and clinician participants reporting impacts on their (or their patients’) physical functioning (e.g., walking), activities of daily living (e.g., household chores) and work. Impacts on emotional well-being (e.g., feeling anxious or worried), social lives, relationships, and sleep were also reported. Shortness of breath and fatigue were spontaneously noted as salient and bothersome symptoms by most patient participants with edema noted by most on probing; this was further corroborated by clinicians who also considered these symptoms as the most bothersome symptoms of HFpEF. This study highlighted the substantial burden of living with HFpEF and obesity. The resultant conceptual model highlights the key concepts that should be considered in patient-focused drug development. This qualitative study involved in-depth interviews with patients and health care professionals to understand the symptoms and impacts of living with heart failure with preserved ejection fraction (HFpEF) and obesity. Findings identified fatigue, shortness of breath, and swelling caused by excess fluid (edema) as core symptoms experienced by patients which subsequently impacted multiple aspects of patients’ lives including physical functioning (e.g., walking), ability to do everyday tasks (e.g., household chores), work, emotions, and sleep. The conceptual model summarizing the identified symptoms and impacts is the first to illustrate the experience of living with HFpEF and obesity and can inform future research and clinical trials for this condition.

Journal of Patient-Reported OutcomesVol. 10(1)
Eli Lilly (United States) (US), Health Economics and Outcomes Research (United Kingdom) (GB)
Good health and well-being
Openalex Percentile: Top 2%
Cardiovascular Function and Risk Factors
30.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.